To Be Discontinued Tablet Endocrinology/Metabolism

Potassium Chloride Tablet, E · 23 active FDA presentation rows for this drug

Brand: POTASSIUM CHLORIDE

FDA lists Potassium Chloride Tablet, E as To Be Discontinued (Upsher-Smith Laboratories, LLC).

No availability text on this FDA row.

Potassium Chloride Tablet, Extended Release: To Be Discontinued

FDA availability text is not recorded on this row. 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Potassium Chloride Tablet, Extended Release
Manufacturer
Upsher-Smith Laboratories, LLC
Dosage Form
Tablet
Presentation
Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-10)
Package NDC
0832-5322-10

Status & Timeline

Status
To Be Discontinued
First Reported
Jul 23, 2025
Last Updated
Jul 23, 2025
Therapeutic Category
Endocrinology/Metabolism, Gastroenterology

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Discontinuation of the manufacture of the drug product

Full Drug Profile

potassium chloride

Side effects, interactions, warnings & more

View Profile
Compare potassium chloride with alternatives →

Nearby, Other Potassium Shortage Records

Potassium Chloride Tablet, Extended Release

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Potassium Chloride Tablet, Extended Release

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Potassium Chloride Tablet, Extended Release

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Potassium Chloride Tablet, Extended Release

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Potassium Chloride Tablet, Extended Release

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Potassium Chloride Tablet, Extended Release

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

FDA reason on file: Discontinuation of the manufacture of the drug product. General shortage guidance lives on the tracker hub.

← All Drug Shortages